End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
5.9
CNY
|
0.00%
|
|
+13.68%
|
-10.61%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,944
|
3,391
|
3,346
|
19,375
|
11,006
|
7,450
|
Enterprise Value (EV)
1 |
4,014
|
3,412
|
3,393
|
19,227
|
10,269
|
6,503
|
P/E ratio
|
-2.02
x
|
-2.26
x
|
-36.1
x
|
68.1
x
|
14.5
x
|
589
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.1
x
|
0.97
x
|
1.92
x
|
11.1
x
|
5.34
x
|
7.19
x
|
EV / Revenue
|
1.12
x
|
0.97
x
|
1.95
x
|
11
x
|
4.98
x
|
6.28
x
|
EV / EBITDA
|
17.8
x
|
-26.4
x
|
-18
x
|
34.8
x
|
10.8
x
|
102
x
|
EV / FCF
|
82.7
x
|
39.8
x
|
35.9
x
|
38.1
x
|
15.3
x
|
34.4
x
|
FCF Yield
|
1.21%
|
2.51%
|
2.79%
|
2.63%
|
6.54%
|
2.91%
|
Price to Book
|
1.91
x
|
3.91
x
|
4.62
x
|
19.6
x
|
6.25
x
|
3.71
x
|
Nbr of stocks (in thousands)
|
1,063,137
|
1,181,399
|
1,157,800
|
1,138,347
|
1,128,820
|
1,128,820
|
Reference price
2 |
3.710
|
2.870
|
2.890
|
17.02
|
9.750
|
6.600
|
Announcement Date
|
4/27/19
|
4/29/20
|
4/23/21
|
4/19/22
|
4/21/23
|
4/23/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,599
|
3,513
|
1,738
|
1,741
|
2,063
|
1,036
|
EBITDA
1 |
225.1
|
-129.3
|
-188.7
|
552.5
|
947
|
63.8
|
EBIT
1 |
206.6
|
-213
|
-250.9
|
488.2
|
875.4
|
-6.609
|
Operating Margin
|
5.74%
|
-6.06%
|
-14.43%
|
28.04%
|
42.44%
|
-0.64%
|
Earnings before Tax (EBT)
1 |
-1,858
|
-1,458
|
-104.9
|
423.1
|
986.4
|
35.54
|
Net income
1 |
-1,954
|
-1,474
|
-87.38
|
287.7
|
773.8
|
12.72
|
Net margin
|
-54.28%
|
-41.96%
|
-5.03%
|
16.53%
|
37.51%
|
1.23%
|
EPS
2 |
-1.838
|
-1.270
|
-0.0800
|
0.2500
|
0.6736
|
0.0112
|
Free Cash Flow
1 |
48.53
|
85.68
|
94.63
|
504.7
|
671.7
|
189
|
FCF margin
|
1.35%
|
2.44%
|
5.44%
|
28.99%
|
32.56%
|
18.25%
|
FCF Conversion (EBITDA)
|
21.56%
|
-
|
-
|
91.35%
|
70.93%
|
296.17%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
175.41%
|
86.81%
|
1,486.14%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/19
|
4/29/20
|
4/23/21
|
4/19/22
|
4/21/23
|
4/23/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
70.2
|
21.1
|
47
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
148
|
737
|
948
|
Leverage (Debt/EBITDA)
|
0.3118
x
|
-0.1632
x
|
-0.2493
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
48.5
|
85.7
|
94.6
|
505
|
672
|
189
|
ROE (net income / shareholders' equity)
|
-56.5%
|
-91.2%
|
-10.9%
|
41.1%
|
55.5%
|
0.56%
|
ROA (Net income/ Total Assets)
|
2.55%
|
-3.63%
|
-5.74%
|
15%
|
22.7%
|
-0.14%
|
Assets
1 |
-76,556
|
40,623
|
1,522
|
1,919
|
3,408
|
-9,227
|
Book Value Per Share
2 |
1.940
|
0.7300
|
0.6300
|
0.8700
|
1.560
|
1.780
|
Cash Flow per Share
2 |
0.1100
|
0.2600
|
0.2700
|
0.1900
|
0.7400
|
0.5900
|
Capex
1 |
47.9
|
59.6
|
50.2
|
27.3
|
82.3
|
43.2
|
Capex / Sales
|
1.33%
|
1.7%
|
2.89%
|
1.57%
|
3.99%
|
4.18%
|
Announcement Date
|
4/27/19
|
4/29/20
|
4/23/21
|
4/19/22
|
4/21/23
|
4/23/24
|
|
1st Jan change
|
Capi.
|
---|
| -10.61% | 884M | | +11.76% | 63.38B | | -3.73% | 46.51B | | +13.40% | 39.91B | | +19.57% | 25.57B | | +7.71% | 18.95B | | +1.44% | 17.58B | | -20.33% | 16.1B | | +0.91% | 14.98B | | -12.98% | 14.78B |
Other Specialty Chemicals
|